Safety: Multaq (dronedarone): Drug Safety Communication - Increased Risk of Death or Serious Cardiovascular Events
If you relate to any of the following, you may be a candidate for GLP-1 Agonist: BMI over 27 (or over 25 with an obesity-related condition like diabetes or high blood pressure) Previous difficulty losing and keeping weight off with diet, exercise, and/or other medications Ready for an extra push to boost your weight loss results Wanting to improve your health by losing excess body weight Our medical providers will thoroughly assess your health profile during a consultation to determine if GLP-1 Agonist is appropriate for your needs and goals
Phenolic compounds in honey, which act as electron or hydrogen donors, directly scavenge ROS
Compounded semaglutide medications might not work as well as the real thing
Covid-19: Semaglutide (ozempic, Wegovy, Rybelsus) Could Impact Death Rate Although patients taking semaglutide during the COVID-19 pandemic had similar rates of COVID-19 infection compared to the placebo group, those taking the drug had a 33% lower risk of dying from coronavirus infection, researchers found
